$9.20
Manufacturer: Italy
Purpose: Blocks histamine receptors to relieve allergy symptoms like itching, sneezing.
Description
Edem (desloratadine) Syrup 0.5 mg/ml. 60 ml
Ingredients
Active ingredient: Desloratadine 0.5 mg/ml.
Dosage
Dosage: The recommended dose for adults and children over 12 years old is 10 ml (5 mg) once daily.
Indications
Indications: Edem syrup is indicated for the relief of symptoms associated with allergic rhinitis and chronic idiopathic urticaria.
Contraindications
Contraindications: Do not use Edem syrup if you are allergic to desloratadine or any of the other ingredients in the product.
Directions
Directions: Shake well before use. Use the provided measuring device to ensure the correct dosage. Do not exceed the recommended dose.
Scientific Evidence
Desloratadine, the active ingredient in Edem syrup, is a selective peripheral histamine H1-receptor antagonist. It works by blocking the action of histamine in the body, thereby reducing symptoms of allergies such as sneezing, itching, and runny nose. Clinical studies have shown that desloratadine is effective in relieving allergy symptoms with a low incidence of sedation compared to other antihistamines.
Additional Information
Edem syrup is well-tolerated, with the most common side effects being headache, dry mouth, and fatigue. It is important to consult a healthcare professional before using this product, especially if you have liver or kidney problems. Keep out of reach of children and store at room temperature.
Clinical Trials and Comparative Effectiveness
Clinical trials have demonstrated the efficacy of desloratadine in improving symptoms of allergic rhinitis and chronic idiopathic urticaria. In comparative studies, desloratadine has shown similar effectiveness to other second-generation antihistamines but with a lower incidence of sedation, making it a preferred choice for individuals who require non-drowsy allergy relief.
Overall, Edem (desloratadine) syrup 0.5 mg/ml. 60 ml is a well-established antihistamine with a proven track record of efficacy and safety in the management of allergic conditions.
Recent Reviews